Navigation Links
Pregnancy Hormone Offers Hope to MS Patients

In a study bound to raise hope in Multiple Sclerosis (MS) patients, researchers have reported significant changes in MS symptoms of mice//, administered with pregnancy hormone prolactin.

Multiple Sclerosis causes the body's immune system to attack the protective coating around immune system This leads to damage that cannot be repaired.

The hormone prolactin secreted during pregnancy and lactation, stimulates breast development and milk production and has been tested in humans for other reasons.

The researchers from the University of Calgary’s Hotckiss Brain Institute, destroyed myelin around the nerve cells in the mice, as seen in MS. Two weeks later, the pregnant mice had twice as much new myelin as the other mice. When the scientists injected prolactin into the non-pregnant mice, their myelin similarly was repaired.

Results were published in the Journal of Neuroscience.

Says Dr. Samuel Weiss director of the Hotckiss Brain Institute,"It's early to be confident that prolactin will definitely work with people, but prolactin represents the first example of any molecule, in this case a naturally occurring molecule, that can actually boost the repair of myelin."

While current MS treatments are designed to prevent new damage in patients in earlier stages of the disease, there is nothing to repair myelin that has already been destroyed.

"This may give us some ways to now focus on protecting the brain, as opposed to giving therapies that just reduce the attacks," said Dr. Jock Murray, a professor of medicine at Dalhousie University and founding director of its multiple sclerosis research unit.

The Calgary team has begun further tests with prolactin on mice to determine whether there are any drawbacks associated with the hormone and whether it can be administered with existing MS medications that target the immune system. It is not known what impact the hormone will have on men.

Sa ys Weiss: “If the next series of studies looks promising, we may be prepared to study prolactin in (human) trials.”
AN
'"/>




Related medicine news :

1. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
2. Pregnancy Blues
3. Smoking Delays Pregnancy
4. Pregnancy should not be confined
5. Pregnancy weight linked to breast cancer
6. Pregnancy complications indicate health problems
7. Pregnancy shouldnt be dissuaded in older age
8. Ginseng Associated with Pregnancy Risks
9. Predicting The Risk Of Preeclampsia During Pregnancy
10. Drugs Taken During Pregnancy Found To Affect Unborn Babies
11. Complications Of Pregnancy May Increase The Risk Of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... , ... April 25, 2017 , ... Lake Park Dental ... by using Invisalign® in Lutz, FL. With the help of this highly-effective, ... aesthetics with fewer potential complications, more discretion and less pain. , Drs. Sarah ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Buyers and ... recreational users to dispensaries and head shops –can’t help but be heartened by the ... the tell-tale cannabis odor aptly described as “skunk smell.” At last they can ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection ... Pink is proud to announce Katie Thiede as their new Chief Executive Officer. In January, ... Chairman of the Board and launched a national search to find a visionary new leader ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
Breaking Medicine Technology: